Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025 |
filingDate |
2005-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2009-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f97765d8c0c40bdbd18a7e9e7a6dd7e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c524fc5ee0715def6de134ac4f9d308 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05dd7d29d19faa8b77b377b660edecec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_903c59a9f5c756585394ecbba0db942a |
publicationDate |
2009-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7563910-B2 |
titleOfInvention |
Heterocyclic cannabinoid receptor antagonists |
abstract |
The present invention relates to compounds of formula I n nand pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CB1 receptors. |
priorityDate |
2004-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |